利用临床参数预测阴性及不确定结果以减少不必要的前列腺多参数磁共振成像
该回顾性研究纳入865例未确诊前列腺癌患者,评估年龄、前列腺体积、PSA及PSA密度对阳性mpMRI(PI-RADS v2/Likert≥4)的预测价值。以PSA密度>0.078 ng/ml²或多元模型可减少25%–29%的mpMRI,且仅遗漏极少数临床显著前列腺癌。需前瞻性验证。
要点
- PSA密度>0.078 ng/ml²可减少25%的mpMRI,阴性预测值95%。
- 多元模型可减少29%的mpMRI,阴性预测值91%。
- 两种策略仅分别遗漏2例和1例临床显著前列腺癌。
核心结论
- 在具有前列腺癌风险的患者中,应用多元预测模型或PSA密度截断值0.078 ng/ml²可减少25%至29%的mpMRI检查,同时仅遗漏极少数临床显著前列腺癌。
研究设计与样本
- 回顾性研究,纳入2009至2017年间865例无前列腺癌病史且接受前列腺mpMRI的患者,分为训练队列605例和验证队列260例。
主要发现
- 所有临床变量均为阳性mpMRI的显著预测因子(p<0.05)。
- PSA密度诊断准确性优于其他参数,与多元模型无显著差异(AUC=0.74 vs 0.75)。
- PSA密度>0.078 ng/ml²时,敏感性94%、特异性29%、阳性预测值22%、阴性预测值95%,减少25%的扫描(64/260)。
- 多元模型敏感性85%、特异性32%、阳性预测值22%、阴性预测值91%,减少29%的扫描(75/260)。
- 未按策略行mpMRI者中,PSA密度策略发现2例临床显著前列腺癌,多元模型发现1例。
关键数值与推荐
- 阳性mpMRI定义为PI-RADS v2/Likert评分≥4。
- PSA密度截断值0.078 ng/ml²用于排除阳性mpMRI,阴性预测值需>90%。
临床怎么用
- 可考虑使用PSA密度或多元模型对前列腺癌风险患者进行分诊,以减少不必要的mpMRI检查。
- 应用这些策略需权衡减少扫描与可能遗漏临床显著前列腺癌的风险。
局限性
- 回顾性研究设计,需进一步前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We sought to develop a triage strategy to reduce negative and indeterminate multiparametric magnetic resonance imaging scans in patients at risk for prostate cancer. MATERIALS AND METHODS: In this retrospective study we evaluated 865 patients with no prior prostate cancer diagnosis who underwent prostate multiparametric magnetic resonance imaging between 2009 and 2017. Age, prostate volume, prostate specific antigen and prostate specific antigen density were assessed as predictors of positive multiparametric magnetic resonance imaging, defined as PI-RADS™ (Prostate Imaging Reporting and Data System) version 2/Likert score 4 or greater. The cohort was split into a training cohort of 605 patients and a validation cohort of 260. The optimal threshold to rule out positive multiparametric magnetic resonance imaging was chosen to achieve a negative predictive value greater than 90%. RESULTS: All clinical variables were significant predictors of positive multiparametric magnetic resonance imaging (p <0.05). Prostate specific antigen density outperformed other parameters in diagnostic accuracy and did not significantly differ compared to a multivariate model (AUC=0.74 vs 0.75). At prostate specific antigen density greater than 0.078 ng/ml2 sensitivity, specificity, positive and negative predictive values were 94%, 29%, 22% and 95%, respectively, resulting in 25% fewer scans (64 of 260). In the multivariate model sensitivity, specificity, positive and negative predictive values were 85%, 32%, 22% and 91%, respectively, resulting in 29% fewer scans (75 of 260). Biopsies in men who would not have undergone multiparametric magnetic resonance imaging according to our proposed strategies revealed 2 clinically significant prostate cancers using prostate specific antigen density and 1 using the multivariate model. CONCLUSIONS: In patients at risk for prostate cancer applying a multivariate prediction model or a prostate specific antigen density cutoff of 0.078 ng/ml2 resulted in 25% to 29% fewer multiparametric magnetic resonance imaging scans performed while missing only a minimal number of clinically significant prostate cancers. Further prospective validation is required.
引用
- Deniffel D, Zhang Y, Salinas E, et al. Reducing Unnecessary Prostate Multiparametric Magnetic Resonance Imaging by Using Clinical Parameters to Predict Negative and Indeterminate Findings. J Urol. 2019. PMID: 31479397. doi:10.1097/JU.0000000000000518
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。